Global Spinal Muscular Atrophy (SMA) Treatment Market Insights and Forecast to 2028

Global Spinal Muscular Atrophy (SMA) Treatment Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type I Spinal Muscular Atrophy (SMA)
1.2.3 Type II Spinal Muscular Atrophy (SMA)
1.2.4 Type III Spinal Muscular Atrophy (SMA)
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Perspective (2017-2028)
2.2 Spinal Muscular Atrophy (SMA) Treatment Growth Trends by Region
2.2.1 Spinal Muscular Atrophy (SMA) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Spinal Muscular Atrophy (SMA) Treatment Market Dynamics
2.3.1 Spinal Muscular Atrophy (SMA) Treatment Industry Trends
2.3.2 Spinal Muscular Atrophy (SMA) Treatment Market Drivers
2.3.3 Spinal Muscular Atrophy (SMA) Treatment Market Challenges
2.3.4 Spinal Muscular Atrophy (SMA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue (2017-2022)
3.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Treatment Revenue
3.4 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2021
3.5 Spinal Muscular Atrophy (SMA) Treatment Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2023-2028)
5 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
6.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
6.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
6.2.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
6.2.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
6.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
6.3.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
6.3.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
6.3.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
6.4 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
6.4.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
6.4.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
7.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
7.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
7.4 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region
8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
9.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
9.2.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
9.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
9.3.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
9.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
9.4.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Introduction
11.1.4 Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Isis Pharmaceuticals
11.2.1 Isis Pharmaceuticals Company Details
11.2.2 Isis Pharmaceuticals Business Overview
11.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
11.2.4 Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
11.2.5 Isis Pharmaceuticals Recent Developments
11.3 Biogen Idec
11.3.1 Biogen Idec Company Details
11.3.2 Biogen Idec Business Overview
11.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Introduction
11.3.4 Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
11.3.5 Biogen Idec Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Introduction
11.4.4 Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
11.4.5 Boehringer Ingelheim Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
11.6.5 Regeneron Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Type I Spinal Muscular Atrophy (SMA)
Table 3. Key Players of Type II Spinal Muscular Atrophy (SMA)
Table 4. Key Players of Type III Spinal Muscular Atrophy (SMA)
Table 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2017-2022)
Table 9. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2023-2028)
Table 11. Spinal Muscular Atrophy (SMA) Treatment Market Trends
Table 12. Spinal Muscular Atrophy (SMA) Treatment Market Drivers
Table 13. Spinal Muscular Atrophy (SMA) Treatment Market Challenges
Table 14. Spinal Muscular Atrophy (SMA) Treatment Market Restraints
Table 15. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Spinal Muscular Atrophy (SMA) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2021)
Table 18. Ranking of Global Top Spinal Muscular Atrophy (SMA) Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service
Table 22. Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Application (2017-2022)
Table 30. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Application (2023-2028)
Table 32. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product
Table 65. Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Isis Pharmaceuticals Company Details
Table 68. Isis Pharmaceuticals Business Overview
Table 69. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
Table 70. Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 71. Isis Pharmaceuticals Recent Developments
Table 72. Biogen Idec Company Details
Table 73. Biogen Idec Business Overview
Table 74. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product
Table 75. Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 76. Biogen Idec Recent Developments
Table 77. Boehringer Ingelheim Company Details
Table 78. Boehringer Ingelheim Business Overview
Table 79. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product
Table 80. Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 81. Boehringer Ingelheim Recent Developments
Table 82. F. Hoffmann-La Roche Company Details
Table 83. F. Hoffmann-La Roche Business Overview
Table 84. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product
Table 85. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 86. F. Hoffmann-La Roche Recent Developments
Table 87. Regeneron Pharmaceuticals Company Details
Table 88. Regeneron Pharmaceuticals Business Overview
Table 89. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
Table 90. Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022) & (US$ Million)
Table 91. Regeneron Pharmaceuticals Recent Developments
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Type I Spinal Muscular Atrophy (SMA) Features
Figure 3. Type II Spinal Muscular Atrophy (SMA) Features
Figure 4. Type III Spinal Muscular Atrophy (SMA) Features
Figure 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Spinal Muscular Atrophy (SMA) Treatment Report Years Considered
Figure 11. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Spinal Muscular Atrophy (SMA) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players in 2021
Figure 15. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2021
Figure 17. North America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Region (2017-2028)
Figure 37. China Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 57. Isis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 58. Biogen Idec Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 61. Regeneron Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs